GORMAN KEVIN CHARLES Insider Trades

Insider Trading History

Track insider trading activity for GORMAN KEVIN CHARLES. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $847k 5,248 shares
Last Trade
May 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$818k 5,248 shares
$155.83
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $122M 756,381 shares
Last Trade
May 19, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$31.7M 205,088 shares
$154.36
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
May 19, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$31.7M 205,088 shares
$154.36
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $82.5M 511,293 shares
Last Trade
May 19, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$37.8M 245,088 shares
$154.33
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $868k 5,377 shares
Last Trade
Feb 13, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$667k 5,377 shares
$124.00
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $84.4M 522,497 shares
Last Trade
Feb 13, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$695k 5,604 shares
$124.00
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $89M 551,293 shares
Last Trade
Feb 13, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.27M 34,380 shares
$124.12
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $84.7M 524,850 shares
Last Trade
Feb 13, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$667k 5,377 shares
$124.00
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $1.81M 11,208 shares
Last Trade
Feb 13, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$695k 5,604 shares
$124.00
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $84.3M 521,949 shares
Last Trade
Feb 13, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$360k 2,901 shares
$124.12
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $83.9M 519,473 shares
Last Trade
Feb 13, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$375k 3,024 shares
$124.12
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $94.6M 585,673 shares
Last Trade
Feb 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.9M 63,724 shares
$124.00
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $83.4M 516,893 shares
Last Trade
Jan 31, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$387k 2,845 shares
$136.06
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $83.9M 519,738 shares
Last Trade
Jan 31, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$700k 5,142 shares
$136.06
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
Jan 31, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$700k 5,142 shares
$136.06
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $100M 620,918 shares
Last Trade
Aug 07, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$13.4M 106,322 shares
$125.60
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $83.1M 514,596 shares
Last Trade
Aug 07, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$13.4M 106,322 shares
$126.41
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
Aug 07, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$13.4M 106,322 shares
$125.60
$161.44
Xencor
Xencor XNCR
Director
Holding Value $266k 18,905 shares
Last Trade
Jun 16, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$29.3k 3,173 shares
$9.22
$14.08
Xencor
Xencor XNCR
Director
Holding Value $385k 27,372 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$258k 27,372 shares
$9.43
$14.08

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up